Argenx Se (ARGX) Receivables - Net (2015 - 2026)

Argenx Se (ARGX) posted quarterly Receivables - Net of $1.9 billion for Q2 2026, down 99.84% year-on-year from $1197.1 billion in Q2 2025, and up 17.24% on a QoQ basis from $1.6 billion in Q4 2025.

Argenx Se (ARGX) Receivables - Net (2015 - 2026) Analysis & Trends

Argenx Se (ARGX) has reported Receivables - Net for 12 consecutive years, with $1.9 billion the latest figure, recorded in Q2 2026.

  • Quarterly Receivables - Net fell 99.84% year-over-year to $1.9 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.9 billion (down 99.84% YoY) and the FY2025 annual result came in at $1.6 billion, up 82.1% from the prior year.
  • Receivables - Net improved to $1.9 billion in Q2 2026 per ARGX's latest filing, from $1.6 billion in the prior quarter.
  • Over the last five years, Receivables - Net for ARGX reached as high as $1197.1 billion in Q2 2025 and fell as low as $112.4 million in Q2 2022.
  • A 5-year average of $133.7 billion and a median of $652.9 million in 2024 frame the typical range for Receivables - Net.
  • Annual changes were most pronounced in 2025 — Receivables - Net jumped 183253.63% — and 2026, when it sank 99.84%.
  • Year by year, Receivables - Net stood at $275.7 million in 2022, then soared by 80.16% to $496.7 million in 2023, then soared by 82.1% to $904.5 million in 2024, then surged by 82.1% to $1.6 billion in 2025, then increased by 17.24% to $1.9 billion in 2026.
  • According to Business Quant data, Receivables - Net over the past three periods registered $1.9 billion, $1.6 billion, and $1197.1 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.93 Bn
Jun 30, 2026 1.93 Bn
Dec 31, 2025 1.65 Bn
Dec 31, 2025 1.65 Bn
Jun 30, 2025 1,197.07 Bn
Jun 30, 2025 1,197.07 Bn
Dec 31, 2024 904.47 Mn
Dec 31, 2024 904.47 Mn
Jun 30, 2024 652.88 Mn
Jun 30, 2024 652.88 Mn
Dec 31, 2023 496.69 Mn
Dec 31, 2023 496.69 Mn
Jun 30, 2023 353.23 Mn
Jun 30, 2023 353.23 Mn
Dec 31, 2022 275.70 Mn
Dec 31, 2022 275.70 Mn
Jun 30, 2022 112.39 Mn
Jun 30, 2022 112.39 Mn
Dec 31, 2021 38.22 Mn
Dec 31, 2021 38.22 Mn